# Ambuja Cements (NSE: AMBUJACEM) share analysis

Canonical: https://vestmind.in/stocks/ambuja-cements  
Source: VestCall by Vestmind, price as of 14 October 2026.

> Ambuja Cements (NSE: AMBUJACEM) was trading at ₹349.3 on 14 October 2026. VestCall scores its business health 53/100 (adequate). On valuation, the price sits in the “Valuation Premium” zone (₹331.78 and above) — above the modelled fair-value range. This is a reading of the evidence, not a buy or sell recommendation.

## Valuation zones

| Zone | Price band | Meaning |
| --- | --- | --- |
| Deeply Discounted | ₹267.45 – ₹288.42 | Furthest below the modelled fair-value range |
| Attractive Valuation | ₹288.42 – ₹320.15 | Below the modelled fair-value range |
| Fairly Valued | ₹320.15 – ₹331.78 | Inside the modelled fair-value range |
| Valuation Premium (current) | ₹331.78 and above | Above the modelled fair-value range |

## The case for and against

- Supports — Shareholding Quality 77/100
- Supports — Management Stability 67/100
- Needs proof — Capital Allocation 18/100
- Needs proof — Business Quality 43/100
- Needs proof — Growth 54/100
- Needs proof — Financial Strength 59/100

## Key ratios

| Ratio | Ambuja Cements | Sector median |
| --- | --- | --- |
| P/E | 7.95x | — |
| P/B | 0.95x | — |
| P/S | 1.21x | — |
| Return on equity (ROE) | 10.7% | — |
| Return on capital employed (ROCE) | 6.3% | — |
| Operating margin | 7.9% | — |
| Net margin | 13.6% | — |
| Current ratio | 0.54x | — |

## Bull, base and bear case (model outputs, not forecasts)

| Scenario | Modelled CAGR | Weight | Assumption |
| --- | --- | --- | --- |
| Bear | −1.1% | 26% | Growth decelerates to 2.9% and the multiple de-rates toward the cohort's trough. |
| Base | +8.0% | 52% | Earnings compound near the measured 8% and the multiple drifts toward its quality-adjusted warranted level. |
| Bull | +14.8% | 22% | Growth holds at 11.3% and the market pays the full premium the measured quality supports. |

## Questions

### Is Ambuja Cements overvalued or undervalued?

At ₹349.3, Ambuja Cements sits in VestCall’s “Valuation Premium” zone (₹331.78 and above): above the modelled fair-value range. Its valuation scores 100/100 (fair) against Unclassified peers. Zones describe where the price sits against modelled value; they are not an instruction to buy or sell.

### Is Ambuja Cements fundamentally strong?

VestCall scores Ambuja Cements’s business health 53/100 (adequate). The strongest measured pillars are shareholding quality and management stability. The ones that need proof are capital allocation and business quality. Each pillar is computed from reported financials, and a pillar whose inputs were not reported is excluded rather than scored as zero.

### What is Ambuja Cements’s P/E ratio?

Ambuja Cements trades at a P/E of 7.95x, on VestCall’s latest read. A multiple only means something against the business it buys: the quality-adjusted fair value on this page weighs it against Ambuja Cements’s returns and growth.

### What are the risks of investing in Ambuja Cements?

The review triggers VestCall watches for Ambuja Cements are: return on equity falls below the quality floor (roe below 15%); revenue growth falls below the thesis floor (revenue cagr below 8%); drawdown from the 52-week high exceeds tolerance (drawdown from 52-week high at or beyond 25%). On the fundamentals, capital allocation is the weakest measured pillar at 18/100. A trigger is a named condition that would change the reading, published so the case against the stock is as visible as the case for it.

### Is this a recommendation to buy or sell Ambuja Cements?

No. VestCall states where Ambuja Cements’s price sits against modelled value, what supports the case and what would break it, with every figure sourced. It does not issue buy, sell or hold calls or price targets. Vestmind is not a SEBI-registered investment adviser or research analyst, and nothing on this page is personalised investment advice.

---

Vestmind is not a SEBI-registered investment adviser or research analyst. This is research for information, not a recommendation or personalised investment advice.